US Broker Ratings

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator with 35.62% Potential Upside

LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry, presents an intriguing opportunity for investors, particularly given its robust potential upside of 35.62%...

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 45% Upside Potential Amid Healthcare Sector Growth

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare industry, is making waves with its impressive market potential, offering savvy investors a tantalizing opportunity..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 74% Upside Potential in Biotech

For investors with an appetite for potential high returns in the healthcare sector, MoonLake Immunotherapeutics (NASDAQ: MLTX) presents a compelling opportunity. As a clinical-stage biotechnology company..

Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: Exploring a 143.94% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands at an intriguing juncture for investors, with a potential upside of 143.94% as highlighted by its average target price of..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Exploring a Potential 263% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing investor interest with its promising pipeline of novel therapies and a staggering potential upside of 263.09%, according to..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Healthcare Innovator with a 47.5% Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) has been making waves in the healthcare sector, particularly in the realm of Medicare Advantage plans. As the company continues to..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 180% Potential Upside in the Biotechnology Sector

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage immunology company specializing in the development of monoclonal antibodies for autoimmune diseases, has recently garnered significant attention in the biotechnology..

Perrigo Company plc (PRGO) Investor Outlook: Unlocking a Potential 38% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO) is a prominent player in the healthcare sector, specializing in the production of over-the-counter health and wellness solutions. With its headquarters..

Merus N.V. (MRUS) Stock Analysis: Analyst Ratings and a Promising 71% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, is making waves in the healthcare sector with its innovative approach to antibody therapeutics. With a market capitalization..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: A Potential 142.95% Upside in the Biotech Sector

Crinetics Pharmaceuticals, Inc. (CRNX), a clinical-stage biotechnology company, has garnered significant attention from investors, driven by its promising portfolio of novel therapeutics targeting rare endocrine diseases..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Biotech Leader with 71.6% Revenue Growth and Promising Gene-Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP), a Swiss-based biotechnology company, is capturing the attention of investors with its revolutionary gene-editing technology and impressive revenue growth. Operating within..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 26.4% Potential Upside in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a stalwart in the healthcare sector, specializes in providing advanced medical devices and technologies, particularly in the field of hospital technology solutions...

Guardant Health, Inc. (GH) Investor Outlook: Analysts See 21.41% Upside Potential

Guardant Health, Inc. (GH), a standout in the healthcare sector, is making waves in the diagnostics and research industry. With its innovative approach to precision oncology,..

Glaukos Corporation (GKOS) Stock Analysis: A 22% Potential Upside in the Booming Medical Devices Sector

In the dynamic world of healthcare, Glaukos Corporation (NYSE: GKOS) stands at the forefront of innovation in medical devices, particularly in the ophthalmic pharmaceutical and medical..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 21.79% Potential Upside

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the eye health industry, stands as a significant player in the healthcare sector specializing in medical..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 282.57% Upside in Biotech Innovation

Vaxcyte, Inc. (PCVX), a prominent player in the biotechnology sector, has emerged as a compelling opportunity for investors looking to tap into the healthcare industry’s growth..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 63% Potential Upside in a Growing Medical Devices Market

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector with its innovative approach to treating obstructive sleep apnea (OSA). As a key..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 54.91% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, continues to capture the attention of investors with its impressive growth metrics and promising..

Option Care Health, Inc. (OPCH) Stock Analysis: A 22% Upside Potential Awaits Investors

Investors with an eye on the healthcare sector should take a closer look at Option Care Health, Inc. (OPCH), a leading provider of home and alternate..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Promising 7.18% Upside with Innovative Organ Transplant Solutions

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the medical devices industry, is capturing investors’ attention with its innovative approach to organ transplant therapy. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds